Does oral hydrocortisone increase the white blood cell count?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Oral Hydrocortisone Raise WBC?

Yes, oral hydrocortisone does raise white blood cell count, with peak increases occurring approximately 48 hours after administration, though the magnitude of increase depends on the dose administered.

Mechanism and Magnitude of WBC Elevation

Glucocorticoids like hydrocortisone cause leukocytosis through well-established mechanisms. The most recent high-quality evidence demonstrates that:

  • Peak effect occurs at 48 hours after steroid administration 1
  • Dose-dependent response: Low-dose steroids increase WBC by approximately 0.3 × 10⁹/L, medium-dose by 1.7 × 10⁹/L, and high-dose by 4.84 × 10⁹/L 1
  • Individual variability exists: Changes can range from -600 to +8,000 cells/mm³, though a given patient's response to a specific dose is reproducible 2

Cellular Changes

The WBC elevation is not uniform across all cell types:

  • Neutrophils increase significantly (mean increase of approximately 4,000-4,600 cells/mm³ with therapeutic doses) 3
  • Lymphocytes decrease concomitantly 2, 3
  • Neutrophil-to-lymphocyte ratio (NLR) increases markedly, with the NLR percentage showing the best discriminatory value (AUC: 0.89) 4

Clinical Implications

Timing Considerations

The WBC response follows a predictable temporal pattern. When hydrocortisone is administered at doses of 200 mg IV or 40 mg oral prednisone equivalent, expect neutrophilia within 3 hours, peaking at 48 hours 1, 2.

Dose-Response Relationship

While higher doses produce more pronounced leukocytosis, even replacement doses used in adrenal insufficiency (15-25 mg/day hydrocortisone) can affect WBC counts 5, 6. The guidelines emphasize using the lowest effective dose to avoid chronic overdosage complications 7, 5.

Important Caveats

Corticosteroid-induced leukocytosis can mask other pathological processes. Recent evidence shows that in patients receiving corticosteroids, the predictive value of WBC count for detecting complications like infection is significantly diminished 8. This is critical when trying to distinguish steroid-induced leukocytosis from infection-related increases.

Individual response variability: While dose correlates with WBC response at the population level, individual patients show variable responses that cannot be predicted by dose alone, though each patient's response to a given dose remains consistent over time 2.

Practical Monitoring Recommendations

When interpreting WBC counts in patients on hydrocortisone:

  • Increases up to 4.84 × 10⁹/L within 48 hours are expected with high-dose steroids 1
  • Larger increases suggest alternative causes (infection, other pathology) 1
  • Any significant increase after low-dose steroids warrants investigation for other etiologies 1
  • Obtain baseline WBC before morning steroid dose when monitoring is clinically important 2

The French consensus guidelines for adrenal insufficiency do not recommend routine hormonal monitoring for glucocorticoid replacement adjustment, instead favoring clinical assessment 9. However, awareness of hydrocortisone's effect on WBC is essential when evaluating patients for potential infections or other complications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.